232 related articles for article (PubMed ID: 25299431)
21. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
[TBL] [Abstract][Full Text] [Related]
22. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
[TBL] [Abstract][Full Text] [Related]
24. Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells.
Kim M; Kim YS; Kim KM; Ko HC; Kim SJ; Kim JH; Kim Y
Integr Cancer Ther; 2014 Nov; 13(6):529-40. PubMed ID: 24838270
[TBL] [Abstract][Full Text] [Related]
25. [Astragalus polysaccharides combined with cisplatin decreases the serum levels of CD44 and collagen type IV and hyaluronic acid in mice bearing Lewis lung cancer].
Ming H; Chen Y; Zhang F; Wang Q; Dong X; Gu J; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):909-13. PubMed ID: 26146060
[TBL] [Abstract][Full Text] [Related]
26. Delta-tocotrienol augments cisplatin-induced suppression of non-small cell lung cancer cells via inhibition of the Notch-1 pathway.
Ji X; Wang Z; Sarkar FH; Gupta SV
Anticancer Res; 2012 Jul; 32(7):2647-55. PubMed ID: 22753722
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
[TBL] [Abstract][Full Text] [Related]
28. Sodium valproate, a histone deacetylase inhibitor, enhances the efficacy of vinorelbine-cisplatin-based chemoradiation in non-small cell lung cancer cells.
Gavrilov V; Lavrenkov K; Ariad S; Shany S
Anticancer Res; 2014 Nov; 34(11):6565-72. PubMed ID: 25368259
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):19-24. PubMed ID: 16415424
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.
Lin CM; Kao WC; Yeh CA; Chen HJ; Lin SZ; Hsieh HH; Sun WS; Chang CH; Hung HS
Nanotechnology; 2015 Mar; 26(10):105101. PubMed ID: 25693888
[TBL] [Abstract][Full Text] [Related]
31. Polysaccharide of Cordyceps sinensis enhances cisplatin cytotoxicity in non-small cell lung cancer H157 cell line.
Ji NF; Yao LS; Li Y; He W; Yi KS; Huang M
Integr Cancer Ther; 2011 Dec; 10(4):359-67. PubMed ID: 21382957
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
33. CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome.
Gvozdenovic A; Arlt MJ; Campanile C; Brennecke P; Husmann K; Li Y; Born W; Muff R; Fuchs B
J Bone Miner Res; 2013 Apr; 28(4):838-47. PubMed ID: 23169460
[TBL] [Abstract][Full Text] [Related]
34. Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway.
Zhang T; Ma L; Wu P; Li W; Li T; Gu R; Dan X; Li Z; Fan X; Xiao Z
Oncol Rep; 2019 Mar; 41(3):1779-1788. PubMed ID: 30747218
[TBL] [Abstract][Full Text] [Related]
35. Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line.
Onoda M; Nakaseko C; Yokota A; Saito Y
Hematology; 2009 Aug; 14(4):213-9. PubMed ID: 19635184
[TBL] [Abstract][Full Text] [Related]
36. Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC).
Zhang BY; Wang YM; Gong H; Zhao H; Lv XY; Yuan GH; Han SR
Int J Clin Exp Pathol; 2015; 8(1):25-37. PubMed ID: 25755690
[TBL] [Abstract][Full Text] [Related]
37. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11.
Zagryazhskaya A; Surova O; Akbar NS; Allavena G; Gyuraszova K; Zborovskaya IB; Tchevkina EM; Zhivotovsky B
Oncotarget; 2015 May; 6(14):12156-73. PubMed ID: 25940438
[TBL] [Abstract][Full Text] [Related]
38. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
Gatti L; Cossa G; Tinelli S; Carenini N; Arrighetti N; Pennati M; Cominetti D; De Cesare M; Zunino F; Zaffaroni N; Perego P
J Pharmacol Exp Ther; 2014 Mar; 348(3):360-71. PubMed ID: 24345465
[TBL] [Abstract][Full Text] [Related]
39. pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect.
Fan X; Zhao X; Qu X; Fang J
Int J Pharm; 2015 Dec; 496(2):644-53. PubMed ID: 26529576
[TBL] [Abstract][Full Text] [Related]
40. Cationic conjugated polymer/fluoresceinamine-hyaluronan complex for sensitive fluorescence detection of CD44 and tumor-targeted cell imaging.
Huang Y; Yao X; Zhang R; Ouyang L; Jiang R; Liu X; Song C; Zhang G; Fan Q; Wang L; Huang W
ACS Appl Mater Interfaces; 2014; 6(21):19144-53. PubMed ID: 25278260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
